Lilly Launches Mounjaro® (tirzepatide) in India for Obesity and Type 2 Diabetes Treatment
Mumbai: Eli Lilly and Company (India) has launched Mounjaro® (tirzepatide), a first-of-its-kind treatment for obesity, overweight, and type 2 diabetes,
Read More